世界のブパルリシブ市場予測 2023年-2029年

◆英語タイトル:Global Buparlisib Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23JU3299)◆商品コード:LP23JU3299
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のブパルリシブ市場」は、過去の販売実績から2022年の世界のブパルリシブの総販売量を検討し、2023年から2029年の予測されるブパルリシブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のブパルリシブの市場規模を掲載し、XXX百万米ドル規模の世界のブパルリシブ市場の詳細な分析を提供します。本インサイトレポートは、世界のブパルリシブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のブパルリシブ市場における各社の独自のポジションをより深く理解するために、ブパルリシブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のブパルリシブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ブパルリシブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ブパルリシブの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ブパルリシブのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ブパルリシブの世界主要メーカーとしては、Selleck Chemicals、 Abcam、 BOC Sciences、 Syd Labs、 Santa Cruz Biotechnology、 Cayman Chemical、 BioVision、 Shimadzu、 Biosynth Carbosynth、 Adooq Bioscience、 Axon Medchem、 TargetMol、 Enzo Biochem、 LGC、 LKT Laboratories、 InvivoChem、 J&K Scientificなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のブパルリシブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではブパルリシブ市場をセグメンテーションし、種類別 (最小純度98%以下、最小純度98-99%、最小純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:最小純度98%以下、最小純度98-99%、最小純度99%以上

・用途別区分:研究、医療

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のブパルリシブ市場の10年間の市場状況・展望は?
・世界および地域別に見たブパルリシブ市場成長の要因は何か?
・ブパルリシブの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ブパルリシブのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ブパルリシブの年間販売量2018-2029、地域別現状・将来分析
・ブパルリシブの種類別セグメント:最小純度98%以下、最小純度98-99%、最小純度99%以上
・ブパルリシブの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ブパルリシブの用途別セグメント:研究、医療
・ブパルリシブの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のブパルリシブ市場
・企業別のグローバルブパルリシブ市場データ:2018-2023年の年間販売量、市場シェア
・企業別のブパルリシブの年間売上:2018-2023年の売上、市場シェア
・企業別のブパルリシブ販売価格
・主要企業のブパルリシブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ブパルリシブの地域別レビュー
・地域別のブパルリシブ市場規模2018-2023:年間販売量、売上
・主要国別のブパルリシブ市場規模2018-2023:年間販売量、売上
・南北アメリカのブパルリシブ販売の成長
・アジア太平洋のブパルリシブ販売の成長
・ヨーロッパのブパルリシブ販売の成長
・中東・アフリカのブパルリシブ販売の成長

南北アメリカ市場
・南北アメリカの国別のブパルリシブ販売量、売上(2018-2023)
・南北アメリカのブパルリシブの種類別販売量
・南北アメリカのブパルリシブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のブパルリシブ販売量、売上(2018-2023)
・アジア太平洋のブパルリシブの種類別販売量
・アジア太平洋のブパルリシブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のブパルリシブ販売量、売上(2018-2023)
・ヨーロッパのブパルリシブの種類別販売量
・ヨーロッパのブパルリシブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のブパルリシブ販売量、売上(2018-2023)
・中東・アフリカのブパルリシブの種類別販売量
・中東・アフリカのブパルリシブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ブパルリシブの製造コスト構造分析
・ブパルリシブの製造プロセス分析
・ブパルリシブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ブパルリシブの主要なグローバル販売業者
・ブパルリシブの主要なグローバル顧客

地域別のブパルリシブ市場予測レビュー
・地域別のブパルリシブ市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ブパルリシブの種類別市場規模予測
・ブパルリシブの用途別市場規模予測

主要企業分析
Selleck Chemicals、 Abcam、 BOC Sciences、 Syd Labs、 Santa Cruz Biotechnology、 Cayman Chemical、 BioVision、 Shimadzu、 Biosynth Carbosynth、 Adooq Bioscience、 Axon Medchem、 TargetMol、 Enzo Biochem、 LGC、 LKT Laboratories、 InvivoChem、 J&K Scientific
・企業情報
・ブパルリシブ製品
・ブパルリシブ販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

Buparlisib is an orally bioavailable and selective pan-class I phosphatidylinositol-3 kinase (PI3K) inhibitor.
LPI (LP Information)’ newest research report, the “Buparlisib Industry Forecast” looks at past sales and reviews total world Buparlisib sales in 2022, providing a comprehensive analysis by region and market sector of projected Buparlisib sales for 2023 through 2029. With Buparlisib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Buparlisib industry.
This Insight Report provides a comprehensive analysis of the global Buparlisib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Buparlisib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Buparlisib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Buparlisib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Buparlisib.
The global Buparlisib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Buparlisib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Buparlisib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Buparlisib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Buparlisib players cover Selleck Chemicals, Abcam, BOC Sciences, Syd Labs, Santa Cruz Biotechnology, Cayman Chemical, BioVision, Shimadzu and Biosynth Carbosynth, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Buparlisib market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Selleck Chemicals
Abcam
BOC Sciences
Syd Labs
Santa Cruz Biotechnology
Cayman Chemical
BioVision
Shimadzu
Biosynth Carbosynth
Adooq Bioscience
Axon Medchem
TargetMol
Enzo Biochem
LGC
LKT Laboratories
InvivoChem
J&K Scientific
Key Questions Addressed in this Report
What is the 10-year outlook for the global Buparlisib market?
What factors are driving Buparlisib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Buparlisib market opportunities vary by end market size?
How does Buparlisib break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Buparlisib Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Buparlisib by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Buparlisib by Country/Region, 2018, 2022 & 2029
2.2 Buparlisib Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Buparlisib Sales by Type
2.3.1 Global Buparlisib Sales Market Share by Type (2018-2023)
2.3.2 Global Buparlisib Revenue and Market Share by Type (2018-2023)
2.3.3 Global Buparlisib Sale Price by Type (2018-2023)
2.4 Buparlisib Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Buparlisib Sales by Application
2.5.1 Global Buparlisib Sale Market Share by Application (2018-2023)
2.5.2 Global Buparlisib Revenue and Market Share by Application (2018-2023)
2.5.3 Global Buparlisib Sale Price by Application (2018-2023)
3 Global Buparlisib by Company
3.1 Global Buparlisib Breakdown Data by Company
3.1.1 Global Buparlisib Annual Sales by Company (2018-2023)
3.1.2 Global Buparlisib Sales Market Share by Company (2018-2023)
3.2 Global Buparlisib Annual Revenue by Company (2018-2023)
3.2.1 Global Buparlisib Revenue by Company (2018-2023)
3.2.2 Global Buparlisib Revenue Market Share by Company (2018-2023)
3.3 Global Buparlisib Sale Price by Company
3.4 Key Manufacturers Buparlisib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Buparlisib Product Location Distribution
3.4.2 Players Buparlisib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Buparlisib by Geographic Region
4.1 World Historic Buparlisib Market Size by Geographic Region (2018-2023)
4.1.1 Global Buparlisib Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Buparlisib Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Buparlisib Market Size by Country/Region (2018-2023)
4.2.1 Global Buparlisib Annual Sales by Country/Region (2018-2023)
4.2.2 Global Buparlisib Annual Revenue by Country/Region (2018-2023)
4.3 Americas Buparlisib Sales Growth
4.4 APAC Buparlisib Sales Growth
4.5 Europe Buparlisib Sales Growth
4.6 Middle East & Africa Buparlisib Sales Growth
5 Americas
5.1 Americas Buparlisib Sales by Country
5.1.1 Americas Buparlisib Sales by Country (2018-2023)
5.1.2 Americas Buparlisib Revenue by Country (2018-2023)
5.2 Americas Buparlisib Sales by Type
5.3 Americas Buparlisib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Buparlisib Sales by Region
6.1.1 APAC Buparlisib Sales by Region (2018-2023)
6.1.2 APAC Buparlisib Revenue by Region (2018-2023)
6.2 APAC Buparlisib Sales by Type
6.3 APAC Buparlisib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Buparlisib by Country
7.1.1 Europe Buparlisib Sales by Country (2018-2023)
7.1.2 Europe Buparlisib Revenue by Country (2018-2023)
7.2 Europe Buparlisib Sales by Type
7.3 Europe Buparlisib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Buparlisib by Country
8.1.1 Middle East & Africa Buparlisib Sales by Country (2018-2023)
8.1.2 Middle East & Africa Buparlisib Revenue by Country (2018-2023)
8.2 Middle East & Africa Buparlisib Sales by Type
8.3 Middle East & Africa Buparlisib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Buparlisib
10.3 Manufacturing Process Analysis of Buparlisib
10.4 Industry Chain Structure of Buparlisib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Buparlisib Distributors
11.3 Buparlisib Customer
12 World Forecast Review for Buparlisib by Geographic Region
12.1 Global Buparlisib Market Size Forecast by Region
12.1.1 Global Buparlisib Forecast by Region (2024-2029)
12.1.2 Global Buparlisib Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Buparlisib Forecast by Type
12.7 Global Buparlisib Forecast by Application
13 Key Players Analysis
13.1 Selleck Chemicals
13.1.1 Selleck Chemicals Company Information
13.1.2 Selleck Chemicals Buparlisib Product Portfolios and Specifications
13.1.3 Selleck Chemicals Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Selleck Chemicals Main Business Overview
13.1.5 Selleck Chemicals Latest Developments
13.2 Abcam
13.2.1 Abcam Company Information
13.2.2 Abcam Buparlisib Product Portfolios and Specifications
13.2.3 Abcam Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abcam Main Business Overview
13.2.5 Abcam Latest Developments
13.3 BOC Sciences
13.3.1 BOC Sciences Company Information
13.3.2 BOC Sciences Buparlisib Product Portfolios and Specifications
13.3.3 BOC Sciences Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BOC Sciences Main Business Overview
13.3.5 BOC Sciences Latest Developments
13.4 Syd Labs
13.4.1 Syd Labs Company Information
13.4.2 Syd Labs Buparlisib Product Portfolios and Specifications
13.4.3 Syd Labs Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Syd Labs Main Business Overview
13.4.5 Syd Labs Latest Developments
13.5 Santa Cruz Biotechnology
13.5.1 Santa Cruz Biotechnology Company Information
13.5.2 Santa Cruz Biotechnology Buparlisib Product Portfolios and Specifications
13.5.3 Santa Cruz Biotechnology Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Santa Cruz Biotechnology Main Business Overview
13.5.5 Santa Cruz Biotechnology Latest Developments
13.6 Cayman Chemical
13.6.1 Cayman Chemical Company Information
13.6.2 Cayman Chemical Buparlisib Product Portfolios and Specifications
13.6.3 Cayman Chemical Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cayman Chemical Main Business Overview
13.6.5 Cayman Chemical Latest Developments
13.7 BioVision
13.7.1 BioVision Company Information
13.7.2 BioVision Buparlisib Product Portfolios and Specifications
13.7.3 BioVision Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 BioVision Main Business Overview
13.7.5 BioVision Latest Developments
13.8 Shimadzu
13.8.1 Shimadzu Company Information
13.8.2 Shimadzu Buparlisib Product Portfolios and Specifications
13.8.3 Shimadzu Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shimadzu Main Business Overview
13.8.5 Shimadzu Latest Developments
13.9 Biosynth Carbosynth
13.9.1 Biosynth Carbosynth Company Information
13.9.2 Biosynth Carbosynth Buparlisib Product Portfolios and Specifications
13.9.3 Biosynth Carbosynth Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biosynth Carbosynth Main Business Overview
13.9.5 Biosynth Carbosynth Latest Developments
13.10 Adooq Bioscience
13.10.1 Adooq Bioscience Company Information
13.10.2 Adooq Bioscience Buparlisib Product Portfolios and Specifications
13.10.3 Adooq Bioscience Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Adooq Bioscience Main Business Overview
13.10.5 Adooq Bioscience Latest Developments
13.11 Axon Medchem
13.11.1 Axon Medchem Company Information
13.11.2 Axon Medchem Buparlisib Product Portfolios and Specifications
13.11.3 Axon Medchem Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Axon Medchem Main Business Overview
13.11.5 Axon Medchem Latest Developments
13.12 TargetMol
13.12.1 TargetMol Company Information
13.12.2 TargetMol Buparlisib Product Portfolios and Specifications
13.12.3 TargetMol Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 TargetMol Main Business Overview
13.12.5 TargetMol Latest Developments
13.13 Enzo Biochem
13.13.1 Enzo Biochem Company Information
13.13.2 Enzo Biochem Buparlisib Product Portfolios and Specifications
13.13.3 Enzo Biochem Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Enzo Biochem Main Business Overview
13.13.5 Enzo Biochem Latest Developments
13.14 LGC
13.14.1 LGC Company Information
13.14.2 LGC Buparlisib Product Portfolios and Specifications
13.14.3 LGC Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 LGC Main Business Overview
13.14.5 LGC Latest Developments
13.15 LKT Laboratories
13.15.1 LKT Laboratories Company Information
13.15.2 LKT Laboratories Buparlisib Product Portfolios and Specifications
13.15.3 LKT Laboratories Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 LKT Laboratories Main Business Overview
13.15.5 LKT Laboratories Latest Developments
13.16 InvivoChem
13.16.1 InvivoChem Company Information
13.16.2 InvivoChem Buparlisib Product Portfolios and Specifications
13.16.3 InvivoChem Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 InvivoChem Main Business Overview
13.16.5 InvivoChem Latest Developments
13.17 J&K Scientific
13.17.1 J&K Scientific Company Information
13.17.2 J&K Scientific Buparlisib Product Portfolios and Specifications
13.17.3 J&K Scientific Buparlisib Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 J&K Scientific Main Business Overview
13.17.5 J&K Scientific Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Buparlisib Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Buparlisib Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Buparlisib Sales by Type (2018-2023) & (Kg)
Table 7. Global Buparlisib Sales Market Share by Type (2018-2023)
Table 8. Global Buparlisib Revenue by Type (2018-2023) & ($ million)
Table 9. Global Buparlisib Revenue Market Share by Type (2018-2023)
Table 10. Global Buparlisib Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Buparlisib Sales by Application (2018-2023) & (Kg)
Table 12. Global Buparlisib Sales Market Share by Application (2018-2023)
Table 13. Global Buparlisib Revenue by Application (2018-2023)
Table 14. Global Buparlisib Revenue Market Share by Application (2018-2023)
Table 15. Global Buparlisib Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Buparlisib Sales by Company (2018-2023) & (Kg)
Table 17. Global Buparlisib Sales Market Share by Company (2018-2023)
Table 18. Global Buparlisib Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Buparlisib Revenue Market Share by Company (2018-2023)
Table 20. Global Buparlisib Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Buparlisib Producing Area Distribution and Sales Area
Table 22. Players Buparlisib Products Offered
Table 23. Buparlisib Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Buparlisib Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Buparlisib Sales Market Share Geographic Region (2018-2023)
Table 28. Global Buparlisib Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Buparlisib Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Buparlisib Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Buparlisib Sales Market Share by Country/Region (2018-2023)
Table 32. Global Buparlisib Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Buparlisib Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Buparlisib Sales by Country (2018-2023) & (Kg)
Table 35. Americas Buparlisib Sales Market Share by Country (2018-2023)
Table 36. Americas Buparlisib Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Buparlisib Revenue Market Share by Country (2018-2023)
Table 38. Americas Buparlisib Sales by Type (2018-2023) & (Kg)
Table 39. Americas Buparlisib Sales by Application (2018-2023) & (Kg)
Table 40. APAC Buparlisib Sales by Region (2018-2023) & (Kg)
Table 41. APAC Buparlisib Sales Market Share by Region (2018-2023)
Table 42. APAC Buparlisib Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Buparlisib Revenue Market Share by Region (2018-2023)
Table 44. APAC Buparlisib Sales by Type (2018-2023) & (Kg)
Table 45. APAC Buparlisib Sales by Application (2018-2023) & (Kg)
Table 46. Europe Buparlisib Sales by Country (2018-2023) & (Kg)
Table 47. Europe Buparlisib Sales Market Share by Country (2018-2023)
Table 48. Europe Buparlisib Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Buparlisib Revenue Market Share by Country (2018-2023)
Table 50. Europe Buparlisib Sales by Type (2018-2023) & (Kg)
Table 51. Europe Buparlisib Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Buparlisib Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Buparlisib Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Buparlisib Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Buparlisib Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Buparlisib Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Buparlisib Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Buparlisib
Table 59. Key Market Challenges & Risks of Buparlisib
Table 60. Key Industry Trends of Buparlisib
Table 61. Buparlisib Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Buparlisib Distributors List
Table 64. Buparlisib Customer List
Table 65. Global Buparlisib Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Buparlisib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Buparlisib Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Buparlisib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Buparlisib Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Buparlisib Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Buparlisib Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Buparlisib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Buparlisib Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Buparlisib Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Buparlisib Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Buparlisib Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Buparlisib Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Buparlisib Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Selleck Chemicals Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 80. Selleck Chemicals Buparlisib Product Portfolios and Specifications
Table 81. Selleck Chemicals Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. Selleck Chemicals Main Business
Table 83. Selleck Chemicals Latest Developments
Table 84. Abcam Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 85. Abcam Buparlisib Product Portfolios and Specifications
Table 86. Abcam Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. Abcam Main Business
Table 88. Abcam Latest Developments
Table 89. BOC Sciences Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 90. BOC Sciences Buparlisib Product Portfolios and Specifications
Table 91. BOC Sciences Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. BOC Sciences Main Business
Table 93. BOC Sciences Latest Developments
Table 94. Syd Labs Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 95. Syd Labs Buparlisib Product Portfolios and Specifications
Table 96. Syd Labs Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Syd Labs Main Business
Table 98. Syd Labs Latest Developments
Table 99. Santa Cruz Biotechnology Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 100. Santa Cruz Biotechnology Buparlisib Product Portfolios and Specifications
Table 101. Santa Cruz Biotechnology Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. Santa Cruz Biotechnology Main Business
Table 103. Santa Cruz Biotechnology Latest Developments
Table 104. Cayman Chemical Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 105. Cayman Chemical Buparlisib Product Portfolios and Specifications
Table 106. Cayman Chemical Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. Cayman Chemical Main Business
Table 108. Cayman Chemical Latest Developments
Table 109. BioVision Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 110. BioVision Buparlisib Product Portfolios and Specifications
Table 111. BioVision Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. BioVision Main Business
Table 113. BioVision Latest Developments
Table 114. Shimadzu Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 115. Shimadzu Buparlisib Product Portfolios and Specifications
Table 116. Shimadzu Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. Shimadzu Main Business
Table 118. Shimadzu Latest Developments
Table 119. Biosynth Carbosynth Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 120. Biosynth Carbosynth Buparlisib Product Portfolios and Specifications
Table 121. Biosynth Carbosynth Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. Biosynth Carbosynth Main Business
Table 123. Biosynth Carbosynth Latest Developments
Table 124. Adooq Bioscience Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 125. Adooq Bioscience Buparlisib Product Portfolios and Specifications
Table 126. Adooq Bioscience Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. Adooq Bioscience Main Business
Table 128. Adooq Bioscience Latest Developments
Table 129. Axon Medchem Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 130. Axon Medchem Buparlisib Product Portfolios and Specifications
Table 131. Axon Medchem Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. Axon Medchem Main Business
Table 133. Axon Medchem Latest Developments
Table 134. TargetMol Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 135. TargetMol Buparlisib Product Portfolios and Specifications
Table 136. TargetMol Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 137. TargetMol Main Business
Table 138. TargetMol Latest Developments
Table 139. Enzo Biochem Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 140. Enzo Biochem Buparlisib Product Portfolios and Specifications
Table 141. Enzo Biochem Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 142. Enzo Biochem Main Business
Table 143. Enzo Biochem Latest Developments
Table 144. LGC Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 145. LGC Buparlisib Product Portfolios and Specifications
Table 146. LGC Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 147. LGC Main Business
Table 148. LGC Latest Developments
Table 149. LKT Laboratories Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 150. LKT Laboratories Buparlisib Product Portfolios and Specifications
Table 151. LKT Laboratories Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 152. LKT Laboratories Main Business
Table 153. LKT Laboratories Latest Developments
Table 154. InvivoChem Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 155. InvivoChem Buparlisib Product Portfolios and Specifications
Table 156. InvivoChem Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 157. InvivoChem Main Business
Table 158. InvivoChem Latest Developments
Table 159. J&K Scientific Basic Information, Buparlisib Manufacturing Base, Sales Area and Its Competitors
Table 160. J&K Scientific Buparlisib Product Portfolios and Specifications
Table 161. J&K Scientific Buparlisib Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 162. J&K Scientific Main Business
Table 163. J&K Scientific Latest Developments
List of Figures
Figure 1. Picture of Buparlisib
Figure 2. Buparlisib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Buparlisib Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Buparlisib Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Buparlisib Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Buparlisib Sales Market Share by Type in 2022
Figure 13. Global Buparlisib Revenue Market Share by Type (2018-2023)
Figure 14. Buparlisib Consumed in Research
Figure 15. Global Buparlisib Market: Research (2018-2023) & (Kg)
Figure 16. Buparlisib Consumed in Medical
Figure 17. Global Buparlisib Market: Medical (2018-2023) & (Kg)
Figure 18. Global Buparlisib Sales Market Share by Application (2022)
Figure 19. Global Buparlisib Revenue Market Share by Application in 2022
Figure 20. Buparlisib Sales Market by Company in 2022 (Kg)
Figure 21. Global Buparlisib Sales Market Share by Company in 2022
Figure 22. Buparlisib Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Buparlisib Revenue Market Share by Company in 2022
Figure 24. Global Buparlisib Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Buparlisib Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Buparlisib Sales 2018-2023 (Kg)
Figure 27. Americas Buparlisib Revenue 2018-2023 ($ Millions)
Figure 28. APAC Buparlisib Sales 2018-2023 (Kg)
Figure 29. APAC Buparlisib Revenue 2018-2023 ($ Millions)
Figure 30. Europe Buparlisib Sales 2018-2023 (Kg)
Figure 31. Europe Buparlisib Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Buparlisib Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Buparlisib Revenue 2018-2023 ($ Millions)
Figure 34. Americas Buparlisib Sales Market Share by Country in 2022
Figure 35. Americas Buparlisib Revenue Market Share by Country in 2022
Figure 36. Americas Buparlisib Sales Market Share by Type (2018-2023)
Figure 37. Americas Buparlisib Sales Market Share by Application (2018-2023)
Figure 38. United States Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Buparlisib Sales Market Share by Region in 2022
Figure 43. APAC Buparlisib Revenue Market Share by Regions in 2022
Figure 44. APAC Buparlisib Sales Market Share by Type (2018-2023)
Figure 45. APAC Buparlisib Sales Market Share by Application (2018-2023)
Figure 46. China Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Buparlisib Sales Market Share by Country in 2022
Figure 54. Europe Buparlisib Revenue Market Share by Country in 2022
Figure 55. Europe Buparlisib Sales Market Share by Type (2018-2023)
Figure 56. Europe Buparlisib Sales Market Share by Application (2018-2023)
Figure 57. Germany Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Buparlisib Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Buparlisib Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Buparlisib Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Buparlisib Sales Market Share by Application (2018-2023)
Figure 66. Egypt Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Buparlisib Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Buparlisib in 2022
Figure 72. Manufacturing Process Analysis of Buparlisib
Figure 73. Industry Chain Structure of Buparlisib
Figure 74. Channels of Distribution
Figure 75. Global Buparlisib Sales Market Forecast by Region (2024-2029)
Figure 76. Global Buparlisib Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Buparlisib Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Buparlisib Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Buparlisib Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Buparlisib Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のブパルリシブ市場予測 2023年-2029年(Global Buparlisib Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆